At a glance
- Originator Roche
- Class Anti-inflammatories; Antirheumatics; Small molecules
- Mechanism of Action Collagenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 21 Aug 1996 Discontinued-Preclinical for Osteoarthritis in Switzerland (PO)
- 21 Aug 1996 Discontinued-Preclinical for Rheumatoid arthritis in Switzerland (PO)
- 21 Aug 1996 An in vitro study has been added to the pharmacodynamics section